Table 3.
T1 versus T2 results: NPS and metabolic parameters.
| Variable | Group | Baseline | Final | t | p | ||
|---|---|---|---|---|---|---|---|
| M | SD | M | SD | ||||
| NPS (pg/mL) | REH | 48.46 | 16.32 | 36.01 | 3.45 | −2.99 | 0.006 |
| CON | 39.67 | 7.14 | 38.96 | 6.76 | −0.30 | 0.766 | |
| Body mass (kg) | REH | 95.50 | 13.92 | 97.06 | 14.09 | 0.34 | 0.736 |
| CON | 88.18 | 12.39 | 85.50 | 13.40 | −0.61 | 0.550 | |
| BMI (kg/m2) | REH | 29.84 | 4.05 | 30.33 | 4.23 | 0.34 | 0.736 |
| CON | 27.39 | 2.81 | 26.54 | 3.09 | −0.84 | 0.408 | |
| Cholesterol total (mg/dL) |
REH | 216.39 | 46.34 | 221.19 | 200.90 | 0.32 | 0.758 |
| CON | 196.48 | 41.35 | 200.90 | 26.41 | 0.37 | 0.713 | |
| HDL (mg/dL) | REH | 42.00 | 5.94 | 41.94 | 5.09 | −0.03 | 0.975 |
| CON | 39.69 | 8.13 | 38.91 | 6.09 | −0.32 | 0.755 | |
| LDL (mg/dL) | REH | 97.00 | 18.30 | 98.88 | 16.52 | 0.30 | 0.763 |
| CON | 111.24 | 25.40 | 104.94 | 22.00 | −0.77 | 0.446 | |
| Triglycerides (mg/dL) | REH | 117.25 | 30.13 | 119.69 | 38.28 | 0.20 | 0.843 |
| CON | 121.88 | 44.28 | 148.59 | 64.56 | 1.41 | 0.169 | |
| Glycaemia (mg/dL) | REH | 91.88 | 9.51 | 98.50 | 15.41 | 1.46 | 0.154 |
| CON | 86.41 | 11.66 | 90.82 | 14.54 | 0.98 | 0.336 | |
| AlAT (IU/L) | REH | 30.50 | 14.80 | 37.44 | 30.69 | 0.81 | 0.422 |
| CON | 29.66 | 18.11 | 30.19 | 9.77 | 0.11 | 0.915 | |
| AspAT (IU/L) | REH | 21.99 | 5.25 | 32.14 | 16.78 | 2.33 | 0.027 |
| CON | 24.42 | 8.23 | 26.11 | 7.70 | 0.62 | 0.541 | |
REH—patient rehabilitation group; CON—patient control group; PANSS factors or subscales as defined by models: anxiety, cognitive, depressive/depression, disorganization, excitement, general, hostility, positive, and negative; NPS—neuropeptide S; BMI—body mass index; HDL—high-density lipoprotein; LDL—low-density lipoprotein; AlAT—alanine transaminase; AspAT—aspartate transaminase; M—mean; SD—standard deviation; t—Student’s t-test; p—p-value significance at p < 0.05.